Preservatives in glaucoma medication
نویسندگان
چکیده
منابع مشابه
Glaucoma and dry eye disease: the role of preservatives in glaucoma medications
Glaucoma is a common cause of irreversible blindness with increasing prevalence. Some of glaucoma patients will also experience dry eye. Dry eye is the most frequent side effect related to benzalkonium chloride (BAC)-containing eye drop used for glaucoma patients. In addition, glaucoma and dry eyes have shared risk factors that are old age and female. Dry eye among glaucoma patients need to be ...
متن کاملGlaucoma Medication Preferences among Glaucoma Specialists in Mexico
Aim To determine the glaucoma specialists' preferences for the different brands of topical glaucoma medications available in Mexico. Materials and methods A web-based survey was sent to 150 board-certified glaucoma specialists in Mexico, with 14 questions related to brand preferences for all glaucoma medications available in Mexico. Participants were asked to select each glaucoma medication c...
متن کاملAntithrombotic medication and incident open-angle glaucoma.
PURPOSE To determine the associations between the use of antithrombotic drugs and incident open-angle glaucoma (OAG). METHODS Ophthalmic examinations including measurements of the IOP and perimetry were performed at baseline and follow-up in 3939 participants of the prospective population-based Rotterdam Study who did not have OAG at baseline. The use of antithrombotic drugs was monitored con...
متن کاملAntihypertensive Medication Postpones the Onset of Glaucoma
Glaucoma is the second most common irreversible cause of blindness worldwide. It is becoming increasingly important in the context of an aging world population. It possesses a considerable challenge to public health because blindness and visual impairment is costly and have a huge impact on life quality. Raised intraocular pressure (IOP) remains the only successful treatable factor to reduce th...
متن کاملApproaches to Anti-Glaucoma Medication Nonadherence
LEARNING OBJECTIVES Upon completion of this activity, participants will be able to: 1. Identify barriers to medication adherence among their patients. 2. Take steps to reduce nonadherence among glaucoma patients. 3. Identify glaucoma patients who may benefi t from sustained-release therapies by increasing awareness of nonadherence with eye drop treatment. 4. Compare diff erent drug-delivery sys...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Ophthalmology
سال: 2018
ISSN: 0007-1161,1468-2079
DOI: 10.1136/bjophthalmol-2017-311544